/Companies

Corteneinc

1 known investors

Find your way into Corteneinc

Sign up to see every warm intro you have to Corteneinc

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Corteneinc team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.

Founders & leadership

GP
Gerard PereiraFounder, President & CEO
SCSanjay Chanda
Sanjay ChandaChief Development Officer
MCMichael Corbett
Michael CorbettChief Business OfficerMichael Corbett brings enterprise software architecture and business analysis expertise, with a background implementing large-scale applications across CRM, business intelligence, and system integration platforms including Salesforce and Cognos.

Investors · 1

Related companies · 2

Companies working in the same space as Corteneinc.

Frequently asked questions

What does Corteneinc do?
Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.
Who founded Corteneinc?
Corteneinc was founded by Gerard Pereira.
Who are Corteneinc's investors?
Corteneinc's investors include Lauder Partners.